dm+d

359380005

Articles

Safety in Lactation: Drugs for urinary frequency, enuresis, and incontinence

25 September 2020This group of drugs have varied mechanisms of action in treating urinary control conditions. Indications are broadly similar for all drugs, although there are small…

Drugs for urinary disorders – are any lactose-free?

5 February 2020This Medicine Q&A gives details of available urinary frequency, enuresis, incontinence and urinary retention preparations that do not contain lactose. There is a lactose-free preparation…
Search Articles

Medicine Compliance Aid Stability

RegurinSpeciality European Pharma

Speciality European Pharma
Regurin
Tablets f/c 20mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
18 September 2015

Regurin XLSpeciality European Pharma

Speciality European Pharma
Regurin XL
Capsules m/r 60mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
No special precautions for storage
Protect from light
18 September 2015

FlotrosGalen Ltd

Galen Ltd
Flotros
Tablets f/c 20mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
18 September 2015

Lactation Safety Information

Oxybutynin
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties although long half-life increases risk of accumulation in breastfed infants
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation
10 August 2020